© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 19, 2014
There are several known risk factors and "red flags" that should prompt clinicians to suspect nonalcoholic steatohepatitis or nonalcoholic fatty liver disease and conduct appropriate testing.
The recently approved antivirals boast improved rates of sustained virologic response and fewer, less-severe side effects compared with older treatments.
Clinicians should be familiar with all current testing options and assessment tools and be prepared to offer support and guidance to patients who may be embarrassed or unwilling to discuss this aspect of their health.
Despite many technological advances, better training and education are the most important factors to boost the detection of adenomas in the colon and reduce interval colorectal cancer.